UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 243

Sortiert nach

E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy

Frontiers in immunology, 2018-01, Vol.8, p.1878-1878

2018

Volltextzugriff (PDF)

Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?

Genes, 2019-11, Vol.10 (12), p.978

2019

Volltextzugriff (PDF)

Advancing cancer immunotherapy: from innovative preclinical models to clinical insights

Scientific reports, 2024-01, Vol.14 (1), p.1205-1205, Article 1205

2024

Volltextzugriff (PDF)

CDG Therapies: From Bench to Bedside

International journal of molecular sciences, 2018-04, Vol.19 (5), p.1304

2018

Volltextzugriff (PDF)

Congenital disorders of glycosylation (CDG): state of the art in 2022

Orphanet journal of rare diseases, 2023-10, Vol.18 (1), p.1-329, Article 329

2023

Volltextzugriff (PDF)

Cardiolipin Membranes Promote Cytochrome c Transformation of Polycyclic Aromatic Hydrocarbons and Their In Vivo Metabolites

Molecules (Basel, Switzerland), 2024-03, Vol.29 (5), p.1129

2024

Volltextzugriff (PDF)

Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases

PloS one, 2017-05, Vol.12 (5), p.e0177829-e0177829

2017

Volltextzugriff (PDF)

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease

Frontiers in neuroscience, 2018-06, Vol.12, p.381-381

2018

Volltextzugriff (PDF)

Sialyl-tn in cancer: (how) did we miss the target?

Biomolecules, 2012-10, Vol.2 (4), p.435-466

2012

Volltextzugriff (PDF)

Immunological aspects of congenital disorders of glycosylation (CDG): a review

Journal of Inherited Metabolic Disease, 2016-11, Vol.39 (6), p.765-780

2016

Volltextzugriff (PDF)

The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)

Orphanet journal of rare diseases, 2022-03, Vol.17 (1), p.134-134, Article 134

2022

Volltextzugriff (PDF)

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers

Journal of experimental & clinical cancer research, 2020-05, Vol.39 (1), p.77-13, Article 77

2020

Volltextzugriff (PDF)

Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors

International journal of molecular sciences, 2023-03, Vol.24 (6), p.5908

2023

Volltextzugriff (PDF)

Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

Orphanet journal of rare diseases, 2022-07, Vol.17 (1), p.1-303, Article 303

2022

Volltextzugriff (PDF)

Inhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation

Molecular oncology, 2018-05, Vol.12 (5), p.579-593

2018

Volltextzugriff (PDF)

Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8725

2022

Volltextzugriff (PDF)

Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review

Orphanet journal of rare diseases, 2018-11, Vol.13 (1), p.215-215, Article 215

2018

Volltextzugriff (PDF)

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

Scientific reports, 2018-08, Vol.8 (1), p.12196-16, Article 12196

2018

Volltextzugriff (PDF)

Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation

BMC health services research, 2017-09, Vol.17 (1), p.682-682, Article 682

2017

Volltextzugriff (PDF)

Sialyl Lewis[sup.X/A] and Cytokeratin Crosstalk in Triple Negative Breast Cancer

Cancers, 2023-02, Vol.15 (3)

2023

Volltextzugriff (PDF)

L1CAM as an E-selectin Ligand in Colon Cancer

International journal of molecular sciences, 2020-11, Vol.21 (21), p.8286

2020

Volltextzugriff (PDF)

Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer

Cancers, 2023-01, Vol.15 (3), p.731

2023

Volltextzugriff (PDF)

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

Molecular oncology, 2014-05, Vol.8 (3), p.753-765

2014

Volltextzugriff (PDF)

Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue

BMC cancer, 2018-05, Vol.18 (1), p.495-495, Article 495

2018

Volltextzugriff (PDF)

Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1

BMC cancer, 2018-02, Vol.18 (1), p.198-198, Article 198

2018

Volltextzugriff (PDF)

1 – 25 von 243

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(229)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy

Artificial Intelligence (AI) in Rare Diseases: Is the Future Brighter?

Advancing cancer immunotherapy: from innovative preclinical models to clinical insights

CDG Therapies: From Bench to Bedside

Congenital disorders of glycosylation (CDG): state of the art in 2022

Cardiolipin Membranes Promote Cytochrome c Transformation of Polycyclic Aromatic Hydrocarbons and Their In Vivo Metabolites

Gla-rich protein function as an anti-inflammatory agent in monocytes/macrophages: Implications for calcification-related chronic inflammatory diseases

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease

Sialyl-tn in cancer: (how) did we miss the target?

Immunological aspects of congenital disorders of glycosylation (CDG): a review

The road to successful people-centric research in rare diseases: the web-based case study of the Immunology and Congenital Disorders of Glycosylation questionnaire (ImmunoCDGQ)

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers

Computational Approaches Drive Developments in Immune-Oncology Therapies for PD-1/PD-L1 Immune Checkpoint Inhibitors

Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

Inhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation

Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)

Patient and observer reported outcome measures to evaluate health-related quality of life in inherited metabolic diseases: a scoping review

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

Public and patient involvement in needs assessment and social innovation: a people-centred approach to care and research for congenital disorders of glycosylation

Sialyl Lewis[sup.X/A] and Cytokeratin Crosstalk in Triple Negative Breast Cancer

L1CAM as an E-selectin Ligand in Colon Cancer

Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer

Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells

Staining of E-selectin ligands on paraffin-embedded sections of tumor tissue

Oxidative damage and response to Bacillus Calmette-Guérin in bladder cancer cells expressing sialyltransferase ST3GAL1

Suchergebnisse filtern